229 related articles for article (PubMed ID: 20027656)
1. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.
Pekow JR; Hetzel JT; Rothe JA; Hanauer SB; Turner JR; Hart J; Noffsinger A; Huo D; Rubin DT
Inflamm Bowel Dis; 2010 Aug; 16(8):1352-6. PubMed ID: 20027656
[TBL] [Abstract][Full Text] [Related]
2. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
3. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
[TBL] [Abstract][Full Text] [Related]
4. Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis.
Fumery M; Dulai PS; Gupta S; Prokop LJ; Ramamoorthy S; Sandborn WJ; Singh S
Clin Gastroenterol Hepatol; 2017 May; 15(5):665-674.e5. PubMed ID: 27916678
[TBL] [Abstract][Full Text] [Related]
5. The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation.
Eaton JE; Smyrk TC; Imam M; Pardi DS; Loftus EV; Owens VL; Talwalkar JA
Aliment Pharmacol Ther; 2013 Oct; 38(8):977-87. PubMed ID: 24033551
[TBL] [Abstract][Full Text] [Related]
6. Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia.
van Schaik FD; ten Kate FJ; Offerhaus GJ; Schipper ME; Vleggaar FP; van der Woude CJ; Stokkers PC; de Jong DJ; Hommes DW; van Bodegraven AA; Siersema PD; Oldenburg B;
Inflamm Bowel Dis; 2011 May; 17(5):1108-16. PubMed ID: 20824815
[TBL] [Abstract][Full Text] [Related]
7. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
[TBL] [Abstract][Full Text] [Related]
8. Risk for colorectal neoplasia in patients with inflammatory bowel disease and mucosa indefinite for dysplasia.
Lai KK; Horvath B; Xie H; Wu X; Lewis BL; Pai RK; Plesec T; Patil DT; Gordon IO; Wang Y; Shen B; Goldblum JR; Liu X
Inflamm Bowel Dis; 2015 Feb; 21(2):378-84. PubMed ID: 25569733
[TBL] [Abstract][Full Text] [Related]
9. Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance.
Mahmoud R; Shah SC; Torres J; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Harpaz N; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1518-1527.e3. PubMed ID: 31446183
[TBL] [Abstract][Full Text] [Related]
10. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
[TBL] [Abstract][Full Text] [Related]
11. Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis.
van Schaik FD; Oldenburg B; Offerhaus GJ; Schipper ME; Vleggaar FP; Siersema PD; van Oijen MG; Ten Kate FJ
Inflamm Bowel Dis; 2012 Mar; 18(3):480-8. PubMed ID: 21509910
[TBL] [Abstract][Full Text] [Related]
12. Dysplasia in ulcerative colitis--clinical consequences?
Sjöqvist U
Langenbecks Arch Surg; 2004 Oct; 389(5):354-60. PubMed ID: 15605166
[TBL] [Abstract][Full Text] [Related]
13. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG
Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086
[TBL] [Abstract][Full Text] [Related]
14. Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer.
Choi CH; Ignjatovic-Wilson A; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Rutter MD; Graham TA; Hart AL
Am J Gastroenterol; 2015 Oct; 110(10):1461-71; quiz 1472. PubMed ID: 26416190
[TBL] [Abstract][Full Text] [Related]
15. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview.
Choi CH; Rutter MD; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Graham TA; Hart AL
Am J Gastroenterol; 2015 Jul; 110(7):1022-34. PubMed ID: 25823771
[TBL] [Abstract][Full Text] [Related]
16. Neoplasia in the ileoanal pouch following colectomy in patients with ulcerative colitis and primary sclerosing cholangitis.
Imam MH; Eaton JE; Puckett JS; Loftus EV; Mathis KL; Gossard AA; Talwalkar JA; Lindor KD
J Crohns Colitis; 2014 Oct; 8(10):1294-9. PubMed ID: 24768559
[TBL] [Abstract][Full Text] [Related]
17. Systematic review with meta-analysis: incidence and factors for progression to advanced neoplasia in inflammatory bowel disease patients with indefinite and low-grade dysplasia.
Wan J; Wang X; Zhang Y; Chen M; Wang M; Wu K; Liang J
Aliment Pharmacol Ther; 2022 Mar; 55(6):632-644. PubMed ID: 35166389
[TBL] [Abstract][Full Text] [Related]
18. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer and dysplasia risk of ulcerative colitis patients in a tertiary referral center in Turkey.
Ünal NG; Özütemiz Ö; Tekin F; Turan İ; Osmanoğlu N
Turk J Gastroenterol; 2019 Feb; 30(2):139-147. PubMed ID: 30460897
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines.
Zisman TL; Bronner MP; Rulyak S; Kowdley KV; Saunders M; Lee SD; Ko C; Kimmey MB; Stevens A; Maurer J; Brentnall TA
Inflamm Bowel Dis; 2012 Dec; 18(12):2240-6. PubMed ID: 22508402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
